The Novartis Pharma AG glomerular filtration rate (GFR) calculator provides healthcare professionals with a simple to use tool for convenient assessment of a patient’s GFR. This result helps to determine the patient’s kidney function.
There are several equations available for estimating GFR. The Novartis Pharma AG GFR calculator offers the options to use the following equations:
- Cockcroft-Gault body surface area (BSA)
- Modification of diet in renal disease (MDRD)
- MDRD with cystatin C
- Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI)�
The application also contains information on prescription medicine Aclasta®.�
Aclasta® is appropriate for the treatment of osteoporosis in patients with an estimated CrCl ≥35 ml/min.
This application is for use by healthcare professionals outside the US only. A key code is required to activate the application which can be generated upon initial launch of the application.
About Aclasta®:
Aclasta® is indicated for treatment of osteoporosis in postmenopausal women. In patients with a recent low-trauma hip fracture, Aclasta reduces the incidence of new clinical fractures.
Aclasta® is indicated for treatment of osteoporosis in men at increased risk of fracture, including those with a recent low-trauma hip fracture.
Aclasta® is indicated for treatment of osteoporosis associated with long-term systemic glucocorticoid therapy in postmenopausal women and in men with increased risk of fracture.
Aclasta® is indicated for the treatment of Paget's disease of the bone. less
|
